Author: AresmaPartner

India’s Paytm curbing low-value personal loans spells bad news for the industry December 7, 2023

Indian financial services firm Paytm sent shockwaves through the industry on Wednesday after it disclosed that it plans to issue fewer personal loans under 50,000 Indian rupees ($600) in a move that has already started to rattle many fintech investors. Paytm’s move followed the RBI recently tightening norms for consumer loans and publicly expressing concerns […]

Commercial companies to collaborate for DARPA’s new lunar economy study December 6, 2023

Establishing commercial markets on the moon is going to require thinking a little differently. That’s DARPA’s hunch, anyway. DARPA (Defense Advanced Research Projects Agency) is the U.S. Department of Defense’s R&D arm, which has just selected 14 companies to participate in a new study to develop technological frameworks for a lunar future. “The next decade […]

HuntX Pharma, BioMapFrance 2024 December 6, 2023

(Grenoble/Biotech/Huntington) – 750K€ c’est la levée en cours de HuntX Pharma qui déploie son candidat médicament HX127 dans le traitement de la maladie de Huntington dont la spécificité est de cibler le transport altéré d’un facteur de survie appelé Brain-Derived Neurotrophic Factor entre le cortex et le striatum. La molécule agit en inhibant une réaction enzymatique […]

Eligo Bioscience, Ciliatech, Omini, Osivax, Sofinnova Partners, Aqemia, Imcheck, BioMapFrance 2024 December 5, 2023

(Paris/Biotech/Edition génétique) – Eligo Bioscience lève 30M$ dans un tour piloté par Sanofi Ventures, suivi de Bpifrance (InnoBio 2), et des historiques d’Eligo Bioscience, Khosla Ventures et Seventure Partners. Ce financement servira à accélérer le développement du programme phare d’Eligo Bioscience, EB005 dans l’acné modérée à sévère, maladie inflammatoire chronique qui touche 3% de la […]